GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $0.0500 $0.0500 Monday, 4th Mar 2024 CFRX stock ended at $0.0500. During the day the stock fluctuated 0% from a day low at $0.0500 to a day high of $0.0500.
90 days $0.0457 $0.0620
52 weeks $0.0430 $3.95

Historical ContraFect Corporation prices

Date Open High Low Close Volume
2023-10-09 $0.510 $0.570 $0.428 $0.452 913 816
2023-10-06 $0.500 $0.540 $0.400 $0.400 52 328
2023-10-05 $0.525 $0.540 $0.500 $0.503 37 463
2023-10-04 $0.541 $0.550 $0.500 $0.548 36 701
2023-10-03 $0.528 $0.580 $0.525 $0.551 14 116
2023-10-02 $0.590 $0.590 $0.521 $0.550 18 651
2023-09-29 $0.580 $0.599 $0.536 $0.570 12 804
2023-09-28 $0.540 $0.580 $0.530 $0.553 35 581
2023-09-27 $0.600 $0.600 $0.530 $0.530 39 090
2023-09-26 $0.603 $0.603 $0.530 $0.580 26 144
2023-09-25 $0.563 $0.620 $0.561 $0.571 11 543
2023-09-22 $0.580 $0.595 $0.542 $0.595 22 871
2023-09-20 $0.626 $0.626 $0.521 $0.565 55 939
2023-09-19 $0.590 $0.600 $0.535 $0.568 53 972
2023-09-18 $0.593 $0.688 $0.510 $0.589 206 704
2023-09-15 $0.593 $0.600 $0.540 $0.566 97 143
2023-09-14 $0.649 $0.650 $0.582 $0.582 52 527
2023-09-13 $0.662 $0.690 $0.618 $0.627 41 259
2023-09-12 $0.670 $0.724 $0.660 $0.661 29 949
2023-09-11 $0.744 $0.781 $0.690 $0.690 103 651
2023-09-08 $0.770 $0.790 $0.730 $0.767 49 078
2023-09-07 $0.789 $1.03 $0.715 $0.80 402 797
2023-09-06 $0.790 $0.85 $0.751 $0.751 55 242
2023-09-05 $0.780 $0.780 $0.730 $0.778 50 468
2023-09-01 $0.766 $0.790 $0.750 $0.750 18 808
Click to get the best stock tips daily for free!

About ContraFect Corporation

ContraFect ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus bacteremia. The company also develops CF-296, an engineered lysin, used for treatment of the in... CFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT